艾德生物: 关于股东减持计划时间届满暨减持股份结果的公告

Core Viewpoint - The major shareholder of Xiamen Aide Biological Technology Co., Ltd. (hereinafter referred to as "Aide Bio") has completed a share reduction plan, resulting in a decrease in their ownership below 5% of the total shares [1][2]. Shareholder Reduction Plan - The shareholder Ningbo Yixiang Self-Funded Investment Partnership (Limited Partnership) planned to reduce its holdings by up to 11,791,800 shares, which is 3.00% of the total share capital, within three months from the announcement date [1]. - As of July 24, 2025, the shareholder's stake was reduced to below 5%, thus no longer qualifying as a major shareholder [1]. Share Reduction Details - The total shares reduced amounted to 11,295,900, representing 2.89% of the total share capital [2]. - Prior to the reduction, the shareholder held 20,026,900 shares (5.10% of total shares), which decreased to 8,731,000 shares (2.23% of total shares) after the reduction [2]. Compliance and Governance - The share reduction was conducted in accordance with relevant laws and regulations, and there were no violations of commitments made by the shareholder [2]. - The company's governance structure and ongoing operations will not be affected, ensuring that control of the company remains unchanged [2].